Effect of Dabigatran (drug) in liver cirrhosis (liver disease)
Not Applicable
- Conditions
- Health Condition 1: K746- Other and unspecified cirrhosis ofliver
- Registration Number
- CTRI/2020/06/025846
- Lead Sponsor
- Institute of Liver and Biliary Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Clinical / radiological /histologic diagnosis of cirrhosis [Childs A&B - CTP <9]
2) Partial / total portal vein thrombosis (chronic)
3) Age- 18-70 years
4) Valid consent
Exclusion Criteria
1) Age > 70 years
2) Presence of active infection ( <2 weeks)
3) Use of anticoagulant drugs in the past 10 days
4) Pregnancy
5) HIV positivity
6) Recent ( <7 days) transfusion with blood products.
7) History of bleeding in last 42 days
HCC / Other malignancy
8)Chronic kidney disease [ CrCl < 30]
9)Drug allergies
10) PVT with cavernoma formation
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method